Cargando…
An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study
BACKGROUND: Physicians strive to improve the postsurgical experience and optimize patient-reported recovery outcome measures (PROMs) following elective cosmetic surgical procedures. Our previous pilot feasibility study demonstrated that twice daily postoperative topical body treatment with tripeptid...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984834/ https://www.ncbi.nlm.nih.gov/pubmed/33791673 http://dx.doi.org/10.1093/asjof/ojaa052 |
_version_ | 1783668118704357376 |
---|---|
author | Casas, Laurie A Bell, Michaela Claytor, Brannon Ziegler, Mary E Widgerow, Alan D |
author_facet | Casas, Laurie A Bell, Michaela Claytor, Brannon Ziegler, Mary E Widgerow, Alan D |
author_sort | Casas, Laurie A |
collection | PubMed |
description | BACKGROUND: Physicians strive to improve the postsurgical experience and optimize patient-reported recovery outcome measures (PROMs) following elective cosmetic surgical procedures. Our previous pilot feasibility study demonstrated that twice daily postoperative topical body treatment with tripeptide and hexapeptide (TransFORM Body Treatment with TriHex Technology [TFB, Alastin Skincare, Inc., Carlsbad, CA]) reduced PROMs of swelling, induration, soft tissue fibrosis, and pain as well as improved visible and palpable skin quality. OBJECTIVES: Evaluate whether adding a tripeptide/hexapeptide anhydrous gel (Regenerating Skin Nectar with TriHex Technology [RSN, Alastin Skincare, Inc., Carlsbad, CA]) pre- and post-procedure to the existing postsurgical regimen of TFB significantly improves 6 PROMs in patients undergoing neck and body contouring cosmetic surgical procedures. METHODS: Ten female patients underwent 15 neck and body contouring procedures and were blindly randomized to 1 of 2 topical treatment protocols (1 [TFB] and 2 [RSN/TFB]) pre- and post-procedure. Patient-reported scores of 5 skin parameters (skin discoloration, ecchymosis, edema, induration, and subcutaneous fibrous banding) and pain scores using the Visual Analog Scale were collected at 8 intervals for 12 weeks post-procedure. RESULTS: The treatment side that used both topicals showed significantly reduced scores of edema, induration, and subcutaneous fibrous banding compared with the side that only used 1 topical, on days 5–7 and 10–14 (P < 0.05). All patients observed slower soft tissue recovery on the side that was treated with TFB alone and opted to break the code and use both topical treatments. CONCLUSIONS: Patients had statistically significant improved patient-reported measures of skin edema, skin induration, and subcutaneous banding on the operated side that used both topicals. LEVEL OF EVIDENCE: 2: [Image: see text] |
format | Online Article Text |
id | pubmed-7984834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79848342021-03-30 An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study Casas, Laurie A Bell, Michaela Claytor, Brannon Ziegler, Mary E Widgerow, Alan D Aesthet Surg J Open Forum Body Contouring BACKGROUND: Physicians strive to improve the postsurgical experience and optimize patient-reported recovery outcome measures (PROMs) following elective cosmetic surgical procedures. Our previous pilot feasibility study demonstrated that twice daily postoperative topical body treatment with tripeptide and hexapeptide (TransFORM Body Treatment with TriHex Technology [TFB, Alastin Skincare, Inc., Carlsbad, CA]) reduced PROMs of swelling, induration, soft tissue fibrosis, and pain as well as improved visible and palpable skin quality. OBJECTIVES: Evaluate whether adding a tripeptide/hexapeptide anhydrous gel (Regenerating Skin Nectar with TriHex Technology [RSN, Alastin Skincare, Inc., Carlsbad, CA]) pre- and post-procedure to the existing postsurgical regimen of TFB significantly improves 6 PROMs in patients undergoing neck and body contouring cosmetic surgical procedures. METHODS: Ten female patients underwent 15 neck and body contouring procedures and were blindly randomized to 1 of 2 topical treatment protocols (1 [TFB] and 2 [RSN/TFB]) pre- and post-procedure. Patient-reported scores of 5 skin parameters (skin discoloration, ecchymosis, edema, induration, and subcutaneous fibrous banding) and pain scores using the Visual Analog Scale were collected at 8 intervals for 12 weeks post-procedure. RESULTS: The treatment side that used both topicals showed significantly reduced scores of edema, induration, and subcutaneous fibrous banding compared with the side that only used 1 topical, on days 5–7 and 10–14 (P < 0.05). All patients observed slower soft tissue recovery on the side that was treated with TFB alone and opted to break the code and use both topical treatments. CONCLUSIONS: Patients had statistically significant improved patient-reported measures of skin edema, skin induration, and subcutaneous banding on the operated side that used both topicals. LEVEL OF EVIDENCE: 2: [Image: see text] Oxford University Press 2020-11-18 /pmc/articles/PMC7984834/ /pubmed/33791673 http://dx.doi.org/10.1093/asjof/ojaa052 Text en © 2020 The Aesthetic Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Body Contouring Casas, Laurie A Bell, Michaela Claytor, Brannon Ziegler, Mary E Widgerow, Alan D An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study |
title | An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study |
title_full | An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study |
title_fullStr | An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study |
title_full_unstemmed | An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study |
title_short | An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study |
title_sort | analysis of patient-reported recovery outcomes of topical tripeptide/hexapeptide formulations utilized in a prospective randomized double-blind split neck and body study |
topic | Body Contouring |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984834/ https://www.ncbi.nlm.nih.gov/pubmed/33791673 http://dx.doi.org/10.1093/asjof/ojaa052 |
work_keys_str_mv | AT casaslauriea ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy AT bellmichaela ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy AT claytorbrannon ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy AT zieglermarye ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy AT widgerowaland ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy AT casaslauriea analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy AT bellmichaela analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy AT claytorbrannon analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy AT zieglermarye analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy AT widgerowaland analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy |